Literature DB >> 2107252

Purification and characterization of intraparenchymal lung lymphocytes.

E Abraham1, A A Freitas, A A Coutinho.   

Abstract

We analyzed phenotypic and functional characteristics of intraparenchymal pulmonary lymphocytes in mice. As determined by flow cytometry, approximately 30% more T cells than B cells were found. Nearly all T cells bore the alpha beta TCR, most of which stained with either CD4+ or CD8+, although small numbers of double-negative T cells were present; the CD8+/CD4+ ratio was approximately 0.37. While practically all B cells bore surface IgM, and no IgA+ cells were found, and approximately more than 80% of the plasma cells produced IgA. Approximately half of the LPS-responsive cells produced IgA. Pulmonary B cell clonal precursors specific for the autoantigen, transferrin, were present in higher frequencies than those specific for the bacterial antigens, levan and Pseudomonas aeruginosa polysaccharide type I, or those producing antibodies against OVA. These results demonstrate that a distinct population of lymphocytes is present in the lungs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2107252

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and RORγt in mice.

Authors:  Yu Yu; Dapeng Wang; Chen Liu; Kane Kaosaard; Kenrick Semple; Claudio Anasetti; Xue-Zhong Yu
Journal:  Blood       Date:  2011-08-19       Impact factor: 22.113

2.  Increase of gammadelta T lymphocytes in murine lungs occurs during recovery from pulmonary infection by Nocardia asteroides.

Authors:  S Tam; D P King; B L Beaman
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

3.  Double-negative T resident memory cells of the lung react to influenza virus infection via CD11c(hi) dendritic cells.

Authors:  K Neyt; C H GeurtsvanKessel; B N Lambrecht
Journal:  Mucosal Immunol       Date:  2015-09-16       Impact factor: 7.313

4.  Pharmacologic inhibition of PKCα and PKCθ prevents GVHD while preserving GVL activity in mice.

Authors:  Kelley M K Haarberg; Jun Li; Jessica Heinrichs; Dapeng Wang; Chen Liu; Crystina C Bronk; Kane Kaosaard; Alexander M Owyang; Sacha Holland; Esteban Masuda; Kin Tso; Bruce R Blazar; Claudio Anasetti; Amer A Beg; Xue-Zhong Yu
Journal:  Blood       Date:  2013-08-01       Impact factor: 22.113

5.  Intrapulmonary concentrations of inflammatory cytokines in a mouse model of chronic respiratory infection caused by Pseudomonas aeruginosa.

Authors:  K Yanagihara; K Tomono; M Kuroki; Y Kaneko; T Sawai; H Ohno; Y Miyazaki; Y Higashiyama; S Maesaki; J Kadota; S Kohno
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

6.  Hemorrhage increases cytokine expression in lung mononuclear cells in mice: involvement of catecholamines in nuclear factor-kappaB regulation and cytokine expression.

Authors:  Y Le Tulzo; R Shenkar; D Kaneko; P Moine; G Fantuzzi; C A Dinarello; E Abraham
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

7.  Cell-mediated cytotoxic responses in lungs following a primary bovine herpes virus type 1 infection.

Authors:  M Campos; P Griebel; H Bielefeldt Ohmann; L A Babiuk
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

8.  Lymphocytes infiltrating normal human lung and lung carcinomas rarely express gamma delta T cell antigen receptors.

Authors:  I Fajac; A Tazi; A J Hance; F Bouchonnet; M Riquet; J P Battesti; P Soler
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

9.  Effects of therapy with soluble tumour necrosis factor receptor fusion protein on pulmonary cytokine expression and lung injury following haemorrhage and resuscitation.

Authors:  E Abraham; W F Coulson; M D Schwartz; J Allbee
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

10.  Activation of macrophages and expansion of specific T lymphocytes in the lungs of mice intratracheally inoculated with Cryptococcus neoformans.

Authors:  K Kawakami; S Kohno; N Morikawa; J Kadota; A Saito; K Hara
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.